Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.

Kashif HussainMuhammad Sohail SalatGul AmbreenAmbreen MughalSidra IdreesMehreen SohailJavaid Iqbal

Published in: Expert opinion on drug safety (2020)

With better lung penetration, ASZ-colistin offers effective and safe microbiological and clinical benefits as adjunctive or alternate treatment of VAP due to colistin susceptible MDR-GNB in neonates.

Keyphrases

multidrug resistant
escherichia coli
pseudomonas aeruginosa
acinetobacter baumannii
drug resistant
klebsiella pneumoniae
gram negative
high dose
low birth weight
intensive care unit
replacement therapy